Inhibition of the TGFβ signaling diminishes the stimulation of the tumor cells by bone matrix-derived TGFβ; thus, breaks the vicious cycle of bone metastasis and, as a consequence, reduces the formation of bone metastases [179,180]. This evidence concerns the gene TGFB1 and neoplasm.